LINC02163 promotes colorectal cancer progression via miR-511-3p/AKT3 axis

References

• Tariq K, Ghias K. Colorectal cancer carcinogenesis: a review of mechanisms. Cancer Biol Med. 2016;13(1):120–135.
   PubMed Web of Science ®Google Scholar
• Kanth P, Grimmett J, Champine M, et al. Hereditary colorectal polyposis and cancer syndromes: a primer on diagnosis and management. Am J Gastroenterol. 2017;112(10):1509–1525.
   PubMed Web of Science ®Google Scholar
• Ogino S, Lochhead P, Giovannucci E, et al. Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology. Oncogene. 2014;33(23):2949–2955.
   PubMed Web of Science ®Google Scholar
• Kordowski F, Kolarova J, Schafmayer C, et al. Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers. BMC Cancer. 2018;18(1):796
   PubMed Web of Science ®Google Scholar
• Binefa G, Rodríguez-Moranta F, Teule à, et al. Colorectal cancer: from prevention to personalized medicine. World J Gastroenterol. 2014;20(22):6786–6808.
   PubMed Web of Science ®Google Scholar
• Cassidy S, Syed BA. Colorectal cancer drugs market. Nat Rev Drug Discov. 2017;16(8):525–526.
   PubMed Web of Science ®Google Scholar
• Friedman RC, Farh KK-H, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92–105.
   PubMed Web of Science ®Google Scholar
• Ramasamy P. MicroRNAs – a new generation molecular targets for treating cellular diseases. Theranostics. 2013;3:927–929.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang Y, Li X, et al. MicroRNA‑212 inhibits colorectal cancer cell viability and invasion by directly targeting PIK3R3. Mol Med Rep. 2017;16(5):7864–7872.
   PubMed Web of Science ®Google Scholar
• Song W, Mei JZ, Zhang M. Long noncoding RNA PlncRNA-1 promotes colorectal cancer cell progression by regulating the PI3K/Akt signaling pathway. Oncol Res. 2018;26(2):261–268.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang L, Chen T, et al. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Mol Cancer. 2019;18(1):28.
   PubMed Web of Science ®Google Scholar
• Shan Y, Ma J, Pan Y, et al. LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1. Cell Death Dis. 2018;9(7):722.
   PubMed Web of Science ®Google Scholar
• Dong YZ, Meng XM, Li GS. Long non-coding RNA SNHG15 indicates poor prognosis of non-small cell lung cancer and promotes cell proliferation and invasion. Eur Rev Med Pharmacol Sci. 2018;22:2671–2679.
   PubMed Web of Science ®Google Scholar
• Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007;129(7):1311–1323.
   PubMed Web of Science ®Google Scholar
• Junxia Z, Anlin Z, Yingyi W, et al. New insights into the roles of ncRNA in the STAT3 pathway. Future Oncol. 2012;8:723–730.
   PubMed Web of Science ®Google Scholar
• Wu Q, Meng W-Y, Jie Y, et al. LncRNA MALAT1 induces colon cancer development by regulating miR-129-5p/HMGB1 axis. J Cell Physiol. 2018;233(9):6750–6757.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Li Z, Ma K, et al. Long non-coding RNA XIST promotes glioma tumorigenicity and angiogenesis by acting as a molecular sponge of miR-429. J Cancer. 2017;8(19):4106–4116.
   PubMed Web of Science ®Google Scholar
• Dong L, Hong H, Chen X, et al. LINC02163 regulates growth and epithelial-to-mesenchymal transition phenotype via miR-593-3p/FOXK1 axis in gastric cancer cells. Artif Cells Nanomed Biotechnol. 2018;46(sup2):607–609.
   PubMed Web of Science ®Google Scholar
• Dong L, Lin W, Qi P, et al. Circulating long RNAs in serum extracellular vesicles: their characterization and potential application as biomarkers for diagnosis of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2016;25(7):1158–1166.
   PubMed Web of Science ®Google Scholar
• Wang C, Yu J, Han Y, et al. Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls. Oncotarget. 2016;7(43):70769–70778.
   PubMedGoogle Scholar
• Nina H, Damjan G. Long non-coding RNA in cancer. Int J Mol Sci . 2013;14:4655–4669.
   PubMed Web of Science ®Google Scholar
• Khorshidi A, Dhaliwal P, Yang BB. Noncoding RNAs in tumor angiogenesis. Adv Exp Med Biol. 2016;927:217–241.
   Google Scholar
• Ouyang S, Zheng X, Zhou X, et al. LncRNA BCAR4 promotes colon cancer progression via activating Wnt/β-catenin signaling. Oncotarget. 2017;8(54):92815–92826.
   PubMedGoogle Scholar
• Zhang F, Wu Z. Significantly altered expression of miR-511-3p and its target AKT3 has negative prognostic value in human prostate cancer. Biochimie. 2017;140:66–72.
   PubMed Web of Science ®Google Scholar
• Nakatani K, Thompson DA, Barthel A, et al. Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. J Biol Chem. 1999;274(31):21528–21532.
   PubMed Web of Science ®Google Scholar
• Agarwal E, Brattain MG, Chowdhury S. Cell survival and metastasis regulation by Akt signaling in colorectal cancer. Cell Signal. 2013;25(8):1711–1719.
   PubMed Web of Science ®Google Scholar